v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Additional paid-in capital
Other additional paid in capital
Other additional paid in capital
Employee stock notes
(Accumulated deficit) retained earnings
Accumulated other comprehensive loss
Foreign currency adjustments
Unrealized gain on foreign currency hedges, net of tax
Unrealized gain (loss) on interest rate hedges, net of tax
Net actuarial pension loss, net of tax
Balance at beginning of period at Dec. 31, 2024     $ 846   $ 769,737 $ (673) $ (20,353) $ (129,495)        
Balance at beginning of period (in shares) at Dec. 31, 2024     84,653,408                  
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards (in shares)     619,074                  
Shares issued for exercise/vesting of share-based compensation awards     $ 6   (4)              
Shares surrendered for tax obligations for employee share-based transactions (in shares)     (55,057)                  
Shares surrendered for tax obligations for employee share-based transactions     $ (1)   (622)              
Amortization of share-based compensation         3,228              
Net loss $ (190,138)           (190,138)          
Foreign currency adjustments 20,813               $ 20,813      
Unrealized gain (loss) on foreign currency hedges, net of tax                   $ (1,300)    
Unrealized gain (loss) on interest rate hedges, net of tax                     $ (35)  
Unrealized gain on commodity hedges, net of tax                     149  
Net actuarial pension gain (loss), net of tax (19)                     $ (19)
Balance at period end (in shares) at Mar. 29, 2025   0                    
Balance at end of period at Mar. 29, 2025 $ 452,139 $ 0 $ 851 $ 771,666 772,339 (673) (210,491) (109,887)        
Balance at period end (in shares) at Mar. 29, 2025     85,217,425                  
Balance at beginning of period (in shares) at Dec. 31, 2025 0                      
Balance at beginning of period at Dec. 31, 2025 $ 92,216   $ 854   783,988 (673) (641,562) (50,391)        
Balance at beginning of period (in shares) at Dec. 31, 2025 85,489,683   85,489,683                  
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards (in shares)     714,885                  
Shares issued for exercise/vesting of share-based compensation awards     $ 7   (5)              
Shares surrendered for tax obligations for employee share-based transactions (in shares)     (83,825)                  
Shares surrendered for tax obligations for employee share-based transactions     $ (1)   (230)              
Reclassification of share-based awards to liability         (90)              
Amortization of share-based compensation         3,682              
Net loss $ (76,844)           (76,844)          
Foreign currency adjustments (6,689)               $ (6,689)      
Unrealized gain (loss) on foreign currency hedges, net of tax                   $ 84    
Unrealized gain (loss) on interest rate hedges, net of tax                     $ 41  
Net actuarial pension gain (loss), net of tax $ 10                     $ 10
Balance at period end (in shares) at Mar. 28, 2026 0 0                    
Balance at end of period at Mar. 28, 2026 $ 12,181 $ 0 $ 860 $ 786,672 $ 787,345 $ (673) $ (718,406) $ (56,945)        
Balance at period end (in shares) at Mar. 28, 2026 86,120,743   86,120,743